Countries North America
Alamar Biosciences, Gates Ventures, and Alzheimer's Disease Data Initiative Launch Global Effort to Build Largest Plasma Proteome Atlas for Alzheimer’s
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer's Disease Data Initiative and Gates ...
June 11, 2025 | News
Eluminex Reports Positive Phase 1 Results for EB-105 in Diabetic Macular Edema Patients
EB-105 Targets VEGF-A, -B, PlGF, Ang-2, and IL-6R Improvements in Visual Acuity and Retinal Edema Observed at All Dose Levels No Safety Issues Observed...
June 10, 2025 | News
ASCO 2025 Showcases New Oncology Paradigms, From Breast Cancer Breakthroughs to AI-Led Precision Medicine
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting wasn’t just another scientific gathering and it was a seismic event that redrew ...
June 06, 2025 | Report
Continuity Biosciences Acquires Focal Medical to Advance Site-Specific Chemotherapy for Pancreatic Cancer
Continuity Biosciences, LLC, a developer of advanced drug delivery technologies, announced the acquisition of Focal Medical, Inc., a North Carol...
June 05, 2025 | News
SCIEX Launches ZenoTOF 8600 System to Redefine Mass Spectrometry Quantitation Across Omics Research
SCIEX, a global leader in life science analytical technologies and operating company of Danaher Corporation (NYSE: DHR), launches the ZenoTOF 86...
June 04, 2025 | News
Protagonist Therapeutics and Takeda Report Positive Phase 3 Results for Rusfertide in PV, Meeting All Primary and Secondary Endpoints
Rusfertide plus current standard of care more than doubled clinical response rates across high- and low-risk PV groups, significantly reducing phleboto...
June 03, 2025 | News
Kexing Biopharm’s GB18 Receives IND Approval in China and U.S. for Cancer Cachexia Treatment
Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) applica...
May 30, 2025 | News
Teddy Laboratory and LabConnect Forge Global Lab Alliance to Accelerate Drug Development
Teddy Laboratory, a subsidiary of Tigermed, officially signed a strategic cooperation agreement with LabConnect, LLC, a global leader in central labor...
May 30, 2025 | News
Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.
YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...
May 26, 2025 | News
Pfizer Strikes $1.25B Ex-China Licensing Deal With China’s 3SBio for Cancer Antibody SSGJ-707
Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutic...
May 20, 2025 | News
Lunit Expands U.S. Footprint with AI-Powered Breast Cancer Screening at Over 200 Sites
Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imagi...
May 20, 2025 | News
BoomerangFX Launches LeadEngineAI™ Featuring AUVIA™ Across North America, Europe, and Asia-Pacific to Transform Patient Acquisition in Private Healthcare Clinics
BoomerangFX, the leading AI-powered SaaS platform for private-pay healthcare clinics, announced the global launch of LeadEngineAI™, a transform...
May 19, 2025 | News
AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders
-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...
May 19, 2025 | News
Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 to Include Brain-Derived pTau Assays for Alzheimer’s and Tauopathy Research
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAse...
May 16, 2025 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
